Drug · DIN 02239517
DIVALPROEX
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since May 27, 2021; first marketed January 20, 1999.
- Drug Identification Number (DIN)
- 02239517
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Valproic acid N03AG01
- Class
- Human
- Record last updated
- August 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VALPROIC ACID (DIVALPROEX SODIUM) | 125 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 27, 2021: NOC 25950Abbreviated New Drug Submission (ANDS) · Change in product ownership
- January 15, 1999: NOC 2015Abbreviated New Drug Submission (ANDS)
Other DINs named DIVALPROEX
- DIN 02239518 · Approved
- DIN 02239519 · Approved
- DIN 02400499 · Dormant
- DIN 02400502 · Dormant
- DIN 02400510 · Dormant